InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Enlivex Ltd.

ENLV Clue Score62
Israel Fiscal year ends December CIK 0001596812
$0.25 -0.39% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.25 −97.28% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 13 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2016Operating income−15.9Net income−16.0Fiscal year 2017Operating income−2.2Net income−2.5Fiscal year 2018Operating income−5.3Net income−4.2Fiscal year 2019Operating income−8.6Net income−9.4Fiscal year 2020Operating income−9.8Net income−11.8EPS, diluted−0.90Fiscal year 2021Operating income−19.3Net income−14.5EPS, diluted−0.81Fiscal year 2022Operating income−25.8Net income−31.1EPS, diluted−1.69Fiscal year 2023Operating income−29.4Net income−29.1EPS, diluted−1.56Fiscal year 2024Operating income−15.9Net income−15.0EPS, diluted−0.73Fiscal year 2025Operating income−15.0Net income1,235.5EPS, diluted25.48
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating income −15.9 −2.2 −5.3 −8.6 −9.8 −19.3 −25.8 −29.4 −15.9 −15.0
Net income −16.0 −2.5 −4.2 −9.4 −11.8 −14.5 −31.1 −29.1 −15.0 1,235.5
Growth
EPS, diluted n/a n/a n/a n/a −0.90 −0.81 −1.69 −1.56 −0.73 25.48

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−15.5Capital expenditure−0.0Free cash flow−15.5Fiscal year 2017Operating cash flow−2.3Capital expenditure−0.1Free cash flow−2.4Fiscal year 2018Operating cash flow−3.2Capital expenditure−0.5Free cash flow−3.6Fiscal year 2019Operating cash flow−7.0Capital expenditure−0.2Free cash flow−7.2Fiscal year 2020Operating cash flow−11.0Capital expenditure−1.0Free cash flow−12.0Fiscal year 2021Operating cash flow−17.5Capital expenditure−1.6Free cash flow−19.2Fiscal year 2022Operating cash flow−24.0Capital expenditure−8.1Free cash flow−32.1Fiscal year 2023Operating cash flow−23.5Capital expenditure−0.2Free cash flow−23.8Fiscal year 2024Operating cash flow−13.0Capital expenditure−0.1Free cash flow−13.1Fiscal year 2025Operating cash flow−10.4Capital expenditure−0.1Free cash flow−10.5
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −15.5 −2.3 −3.2 −7.0 −11.0 −17.5 −24.0 −23.5 −13.0 −10.4
Capital expenditure −0.0 −0.1 −0.5 −0.2 −1.0 −1.6 −8.1 −0.2 −0.1 −0.1
Free cash flow −15.5 −2.4 −3.6 −7.2 −12.0 −19.2 −32.1 −23.8 −13.1 −10.5
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash and securitiesTotal debt
Fiscal year 2016Cash and securities3.0Shareholders’ equity2.8Fiscal year 2017Cash and securities9.0Shareholders’ equity8.5Fiscal year 2018Cash and securities9.7Shareholders’ equity9.7Fiscal year 2019Cash and securities3.9Shareholders’ equity11.3Fiscal year 2020Cash and securities5.7Total debt30.0Net cash (debt)−24.4Shareholders’ equity35.5Debt to equity0.85Fiscal year 2021Cash and securities74.1Total debt10.0Net cash (debt)64.1Shareholders’ equity85.0Debt to equity0.12Fiscal year 2022Cash and securities50.2Total debt0.3Net cash (debt)49.9Shareholders’ equity56.8Debt to equity0.01Fiscal year 2023Cash and securities5.9Shareholders’ equity30.1Fiscal year 2024Cash and securities3.5Shareholders’ equity23.6Fiscal year 2025Cash and securities1.9Shareholders’ equity1,934.9
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and securities 3.0 9.0 9.7 3.9 5.7 74.1 50.2 5.9 3.5 1.9
Total debt n/a n/a n/a n/a 30.0 10.0 0.3 n/a n/a n/a
Net cash (debt) n/a n/a n/a n/a −24.4 64.1 49.9 n/a n/a n/a
Shareholders’ equity 2.8 8.5 9.7 11.3 35.5 85.0 56.8 30.1 23.6 1,934.9
Debt to equity n/a n/a n/a n/a 0.85 0.12 0.01 n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
8.9 1.7 4.0 5.6 6.1 12.9 18.7 19.0 10.6 9.2
5.9 0.5 1.3 3.0 3.7 6.4 7.1 6.1 4.9 5.8
−15.9 −2.2 −5.3 −8.6 −9.8 −19.3 −25.8 −29.4 −15.9 −15.0
Growth
−15.8 −5.9 −2.1 9.4 11.8 14.5 n/a −29.1 −15.0 1,618.2
0.2 0.0 −0.0 n/a n/a n/a n/a n/a n/a 382.6
−16.0 −2.5 −4.2 −9.4 −11.8 −14.5 −31.1 −29.1 −15.0 1,235.5
Growth
Per share
n/a n/a n/a n/a −0.90 −0.81 −1.69 −1.56 −0.73 27.04
n/a n/a n/a n/a −0.90 −0.81 −1.69 −1.56 −0.73 25.48
Growth
n/a n/a n/a n/a n/a 17.9 18.4 18.6 20.5 45.7
n/a n/a n/a n/a n/a 17.9 18.4 18.6 20.5 48.5
Growth +3.0% +1.0% +10.4%

† The diluted share count jumps at 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 9 of 10 years on file.